RSY Merrill Lynch & Co. Strategic Return Notes Linked TO The Select 10 Index

Recom Managed Systems (AMEX:RSY) announced that it has named Susan Keitt as Director of Recom's Cardiac Services Division and Alaine Sosebee as Clinical Manager of Cardiac Services. These appointments complete the division's management team and allow Recom to immediately implement its plan for a full-service ambulatory monitoring center, which will begin operations upon introduction of the company's Model 100 Heart Monitor in settings outside the physician's office. "Susan Keitt and Alaine Sosebee collectively bring invaluable experience in the cardiac-monitoring marketplace to Recom, and we are pleased to have them on board to administer our monitoring services," said Pamela Bunes, president and chief executive officer of Recom. "Their expertise will complement our ongoing preparations to monitor electrocardiograph signals from patients using Recom's Model 100 or the other monitoring products we have developed and those that are under development." Ms. Keitt has distinguished herself in the monitoring industry, most recently as the national director of Holter services for Lifewatch, a division of Card Guard, Inc. Prior to that, she was the national director for Monitor Medx Cardiac Monitoring Service Center. Ms. Keitt also is an expert in complex cardiac-monitoring reimbursement topics, which will be an asset to Recom. She was director of reimbursement for MRM Monitoring and a former division administrator for Tokos Medical, Inc. Ms. Keitt is a graduate of the University of South Carolina with a degree in business administration. Ms. Sosebee formerly was the national manager of Holter services for Lifewatch; prior to that, she served as the clinical manager for Monitor Medx. She has 17 years of direct clinical experience in hospital-based cardiac monitoring that will allow Recom to better identify opportunities to modify its proprietary signal-processing technology for other applications within the hospital environment. About Recom Managed Systems, Inc. Recom Managed Systems, Inc. is an emerging life-sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Recom Managed Systems, Inc. uses its patented signal technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting. With its patented signal-technology platform, Recom brings clinical-quality physiological signal monitoring to the ambulatory setting. Recom's first product, the Model 100 Heart Monitor, is an ambulatory patient heart monitor that uses patented signal-processing technology to record a clinical-quality ECG signal in the presence of interference generated by the patient's body movements and ambient environment. The Model 100 has received 510(k) clearance from the Food and Drug Administration. Recom Managed Systems, Inc. is traded on the American Stock Exchange under the symbol RSY. More information is located at http://www.recom-systems.com Caution Regarding Forward-Looking Statements Statements in this release that are not strictly historical are "forward-looking" statements. Forward-looking statements involve known and unknown risks, which may cause Recom's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to, failure to complete the development and introduction of new products or services, failure to obtain federal or state regulatory approvals governing medical devices, monitoring and other related services or products, inability to obtain physician, patient or insurance acceptance of Recom's products or services, adverse equity-market conditions and declines in the value of Recom's common stock, and the unavailability of financing to complete management's plans and objectives. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Recom's filings with the Securities and Exchange Commission.